Загрузка...
Dual bronchodilation in COPD: lung function and patient-reported outcomes – a review
Several fixed-dose combinations (FDCs) of long-acting bronchodilators (a long-acting muscarinic antagonist [LAMA] plus a long-acting β(2)-agonist [LABA]) are available for the treatment of COPD. Studies of these FDCs have demonstrated substantial improvements in lung function (forced expiratory volu...
Сохранить в:
| Опубликовано в: : | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5221557/ https://ncbi.nlm.nih.gov/pubmed/28115839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S116719 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|